Despite attempts by Takeda Pharmaceuticals and Elli Lily, the U.S.’s second largest verdict in 2014 will stand, reports Bloomberg News. At issue is a staggering $9 billion punitive-damage award handed down over allegations that the drug company concealed knowledge of Actos bladder cancer risks. The... Read More

The attorneys at Injury Lawyer News understand the importance of higher education and are excited to announce a new scholarship program for pre law and law school students who are faced with physical or learning disabilities. As part of our ongoing mission to give back... Read More

A recent status conference for coordinated Actos bladder cancer lawsuits in federal court indicates litigation continues to move forward. Attorneys involved in the Actos MDL were scheduled to meet with the judge overseeing the coordination on August 21, to provide updates about case statuses for the... Read More

Drug giants Takeda Pharmaceuticals and partner Eli Lilly say that a jury acted with passion and prejudice, rather than reason and evidence, to grant an award of $9 billion to a married couple in a landmark Actos bladder cancer lawsuit verdict. In April, after only... Read More

In a June 20 memorandum and ruling issued by the honorable Rebecca Doherty, the federal judge stated that ample evidence indicates that Takeda Pharmaceuticals, maker of Actos, has acted in bad faith during litigation by intentionally destroying key documents pertaining to bladder cancer risks. The... Read More

According to Harris Martin, Takeda is facing new legal action from Blue Cross and Blue Shield of Massachusetts Inc. The lawsuit is attempting to secure damages for claims paid out by the healthcare providers to patients who were diagnosed with bladder cancer after taking the... Read More

On May 22, 2014, a jury returned a verdict in favor of the manufacturer defendant in a Las Vegas Actos trial. The suit was filed by two women who developed bladder cancer after taking the diabetes drug. The women sought $60 million in compensatory damages... Read More

The diabetes drug Actos, once highly-touted as a virtual cure-all for Type 2 diabetes sufferers, is under nationwide scrutiny due to the emerging link between the drug and the sudden onset of bladder cancer. With litigation ongoing across the U.S., a Nevada court is currently... Read More